Kinnate Biopharma Inc.
NASDAQ:KNTE
2.65 (USD) • At close April 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 56.998 | 29.261 | 116.096 | 365.462 | 76.453 | 6.999 |
| Short Term Investments
| 97.036 | 172.214 | 103.362 | 31.398 | 0 | 0 |
| Cash and Short Term Investments
| 154.034 | 201.475 | 219.458 | 396.86 | 76.453 | 6.999 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0.973 | 1.078 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.143 | 3.637 | 5.639 | 3.343 | 0.025 | 0 |
| Total Current Assets
| 158.177 | 230.837 | 258.69 | 400.203 | 77.451 | 8.077 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 4.76 | 6.448 | 0.956 | 0.368 | 0.154 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 10.63 | 39.139 | 105.449 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.038 | 2.402 | 1.769 | 0 | 0 | 0 |
| Total Non-Current Assets
| 15.428 | 47.989 | 108.174 | 0.368 | 0.154 | 0 |
| Total Assets
| 173.605 | 278.826 | 366.864 | 400.571 | 77.605 | 8.077 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.031 | 2.97 | 3.148 | 3.94 | 0.956 | 0.442 |
| Short Term Debt
| 0.892 | 0.991 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 9.072 | 13.206 | 9.239 | 3.364 | 0.989 | 0.025 |
| Total Current Liabilities
| 11.995 | 17.167 | 12.387 | 7.304 | 1.945 | 0.467 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 2.283 | 3.191 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 35 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 2.283 | 3.191 | 35 | 0 | 93.146 | 0 |
| Total Liabilities
| 14.278 | 20.358 | 12.387 | 7.304 | 95.091 | 0.467 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 400.571 | 93.146 | 0 |
| Common Stock
| 0.005 | 0.004 | 0.004 | 0.004 | 0 | 0 |
| Retained Earnings
| -372.012 | -259.363 | -143.092 | -53.329 | -17.568 | -7.63 |
| Accumulated Other Comprehensive Income/Loss
| -0.012 | -1.41 | -0.524 | -0.009 | 0 | 0 |
| Other Total Stockholders Equity
| 531.346 | 484.237 | 463.089 | 46.03 | -93.064 | 15.24 |
| Total Shareholders Equity
| 159.327 | 223.468 | 319.477 | 393.267 | -17.486 | 7.61 |
| Total Equity
| 159.327 | 258.468 | 354.477 | 393.267 | -17.486 | 7.61 |
| Total Liabilities & Shareholders Equity
| 173.605 | 278.826 | 366.864 | 400.571 | 77.605 | 8.077 |